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Abstract In general, disabilities are considered a conse-
quence of frailty rather than a cause of frailty, whereas in
people with intellectual disabilities (ID), disabilities are
often lifelong, which could have consequences for the
feasibility and validity of frailty instruments. To better
understand frailty in people with ID, we compared two
broadly used concepts: the frailty phenotype (FP) and the
frailty index (FI) taking into account their feasibility (e.g.,
percentage of participants able to complete the frailty
assessments), agreement, validity (based on 5-year mor-
tality risk), influence of motor disability, and the relation
between single frailty variables and mortality. The FI and
an adapted version of the FP were applied to a represen-
tative dataset of 1050 people with ID, aged 50 years and
over. The FI was feasible in a larger part of the dataset
(94 %) than the adapted FP: 29 % for all five items, and
81 % for at least three items. There was a slight agreement
between the approaches (j = 0.3). However defined,
frailty was related with mortality, but the FI showed higher
discriminative ability and a stronger relation with mortal-
ity, especially when adjusted for motor disabilities. Con-
cluding, these results imply that the used FI is a stronger
predictor for mortality and has higher feasibility than our
adaptation of the FP, in older people with ID. Possible
explanations of our findings are that we did not use the
exact FP variables or that the FI includes multiple health
domains, and the variables of the FI have lower sensitivity
to lifelong disabilities and are less determined by mobility.
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Introduction
Frailty is a complex cascade that involves several age-re-
lated physiological alterations, eventually leading to loss of
function and failure to respond to a stressor event (Clegg
et al. 2013). The frailty ‘phenotype’ by Fried et al. (2001),
and the frailty index (FI) developed by Rockwood and
Mitnitski (Mitnitski et al. 2001; Rockwood and Mitnitski
2007) are the most evaluated and most frequently used
measures, representing two different concepts and defini-
tions of frailty (Bouillon et al. 2013).
The frailty phenotype was operationalized as a biolog-
ical syndrome, based on a cluster of symptoms that are
commonly observed in frail older people including unin-
tended weight loss, low grip strength, exhaustion, slow gait
speed, and low physical activity (Fried et al. 2001). The
underlying concept is the cycle of frailty, based on age-
related physiological changes, including low energy
expenditure, nutritional deficiencies, and sarcopenia.
Because the frailty phenotype has a clear underlying eti-
ology, it is, although correlated to, distinct from disabilities
and chronic disease (Fried et al. 2004). The frailty phe-
notype distinguishes between three different frailty states,
based on the number of symptoms present in a person. If
none of the symptoms are present, a person is classified as
non-frail, one or two marks a person as pre-frail, and frailty
is defined as the presence of three or more. The frailty
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phenotype can relatively easily be used as a clinical
assessment for frailty, using clearly described cut-off
values.
The FI operationalizes frailty quantitatively as an
aspecific accumulation of health deficits in multiple
domains, and can include health variables such as signs,
diseases, disabilities, laboratory abnormalities, and symp-
toms as long as they are not too common or too rare,
generally increase with age, and together cover several
health domains. In order to find an FI that best captures the
risk for adverse health outcomes, it has been suggested to
also include disabilities and diseases (Theou et al. 2012).
The FI-score is a continuous value between 0 and 1.
Because of the continuous nature of the FI, it is possible to
study individual changes over time, as frailty is usually an
irregular trajectory influenced by stress and recovery
(Mitnitski et al. 2012). On the other hand, on a population
level, the FI shows very regular characteristics including an
exponential relation with age (Mitnitski et al. 2013).
The two approaches agree that, as a consequence of
multisystem deterioration, frailty is an age-related state of
vulnerability to adverse health outcomes (Theou and
Rockwood 2015). Nevertheless, because of different
underlying conceptualizations and operationalizations, it
has been suggested not to compare the two instruments but
rather consider them as complementary to one other (Ce-
sari et al. 2014). Even so, to better understand frailty in
populations with different characteristics, it can be helpful
to compare different concepts. Previous comparisons
showed that the FI has a somewhat stronger relation with
negative health outcomes than the phenotype approach
(Theou and Rockwood 2015).
In people with intellectual disabilities (ID), insights into
how frailty originates, develops, and affects health out-
comes are currently speculative. Results from the general
population cannot directly be applied to this group, because
of their lifelong disabilities (cognitive, motor, and sensory)
and chronic comorbidity, which may influence both the
development and the consequences of frailty. Moreover,
muscle function and mobility play a central role in the
frailty phenotype, whereas these frailty characteristics
could be lifelong in people with ID and highly determine
the frailty status (Evenhuis et al. 2013).
A better understanding of the different concepts of
frailty in people with ID can help improve the under-
standing of frailty in people with ID and better understand
how people with ID age. Furthermore, it provides insight
and direction for a future-screening instrument for frailty in
this lifelong disabled population.
The main aim of our study was therefore to compare the
feasibility and validity of the frailty phenotype and the
frailty index in older adults with ID. First, feasibility was
assessed by evaluating the percentage of participants able
to complete the frailty assessments. Second, validity was
assessed. Because there is no gold standard for frailty,
validity is usually based on criterion validity, in this case
the relation with adverse health outcomes. We therefore
calculated the relation between frailty and 5-year survival.
Third, in addition to general feasibility and criterion
validity, we were interested in the predictive value of the
single items that are part of the frailty phenotype and the FI
in order to find risk factors that highly contribute to the
mortality risk of people with ID. Last, because lifelong
motor disabilities can highly determine the frailty status,
we evaluated the influence of motor disability on the frailty
status.
Methods
Study design and participants
This study was part of the HA-ID study. This study
addressed the health of 1050 older people with ID in the
Netherlands. Details about the recruitment and selection
process have been described elsewhere (Hilgenkamp et al.
2011). Briefly, the study sample consisted of clients, aged
50 years and over, from three Dutch care provider services
offering a broad spectrum of care and support to people
with ID. All clients aged 50 years and over (N = 2322)
were invited to participate. Eventually 1050 clients, or their
legal representatives, provided informed consent, forming
a nearly representative study sample for the Dutch popu-
lation of older adults (aged 50 and above) with ID who use
formal care, albeit with a slight underrepresentation of
men, people aged 80 and over, and people living inde-
pendently. Ethical clearance was provided by the Medical
Ethics Committee of the Erasmus Medical Center Rotter-
dam (MEC 2008-234) and by the ethics committees of the
participating care organizations. The study followed the
guidelines of the Declaration of Helsinki.
Data collection
Baseline data were collected between February 2009 and
July 2010 within three main themes: (1) physical activity
and fitness, (2) nutrition and nutritional state, and (3) mood
and anxiety. Within these themes the participants under-
went an extensive diagnostic assessment including a
physical assessment, a fitness test battery, several ques-
tionnaires (regarding, e.g., nutrition, depression, disabili-
ties), and laboratory tests in addition to the collection of
health record data. Data on age, gender, and residential
status were collected through the care provider services.
Level of ID was obtained from the scores determined by
psychologists or test assistants from available IQ tests. The
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diagnosis of Down syndrome was retrieved from medical
files. Up to March 2015, all-cause mortality data (time of
death) were collected through the care organizations.
Frailty measures
Frailty phenotype
Previously, an adapted version of the frailty phenotype was
applied using the criteria of the Cardiovascular Health
Study (Evenhuis et al. 2012; Fried et al. 2001). According
to the original criteria, an individual should be classified as
frail if at least three of the following five are present:
weight loss, weakness, slowness, low physical activity, and
poor endurance or exhaustion. Briefly, weight loss was
defined as losing more than 3 kg within 3 months. Weak-
ness was assessed using a handgrip dynamometer. Slow-
ness was assessed using comfortable walking speed,
measured as the average of three recordings of the time to
complete a distance of 5 m. Participants in a wheelchair
and participants unable to perform the walking test due to
physical limitations were also classified as having a slow
walking speed. Low physical activity was defined as
walking fewer than 5000 steps/day measured with
pedometers (NL-1000; New Lifestyles, Lees Summit,
MO). Participants in a wheelchair and participants unable
to perform the test due to physical limitations were also
classified as having low physical activity (less than
5000 steps/day). Exhaustion was defined as answering
‘moderate problem’ or ‘severe problem’ to the ‘lacks
energy’ item from the Anxiety, Depression, and Mood
Scale (Esbensen et al. 2003). Additional information about
the used frailty phenotype variables and the originally
intended frailty phenotype criteria are provided in Table 5.
Individuals with one or two criteria present were classified
as pre-frail. Individuals with no criteria present were
classified as non-frail or ‘robust.’ At least three out of five
criteria needed to be known before the frailty phenotype
could be applied.
Frailty index
An FI was previously created with 51 baseline items from
the HA-ID study (Schoufour et al. 2013). A standardized
procedure was followed to develop the FI (Searle et al.
2008): all items were (1) related to health, (2) positively
associated with age, (3) frequently but not too often present
in the population ([5 %,\80 %), and (4) measured in at
least 70 % of the participants. Furthermore, the items did
not correlate too strongly with each other (r\ 0.7), and
together the items covered a range of health problems
(physical, psychological, and social). Deficits included are,
for example, mobility, calf circumferences, bathing,
falling, listless, grip strength, HDL cholesterol, and
knowing which year it is. An overview of all the deficits
included in the FI is provided in Table 4. All items were
recorded between 1 (presence of the deficit) and 0 (absence
of the deficit). The FI-score was calculated as the total
number of deficits present as a proportion of those counted
(e.g., 12 deficits in a 51-item FI results in an FI of
12/51 = 0.24). In the case of missing data, the deficit was
removed from both the numerator and the denominator, but
at least 30 deficits were required per individual. For the
sake of direct comparisons with Fried phenotype, we used
several previously identified cut points. Because using cut
points for the FI is generally not advised and cut-offs are
arbitrary, we applied three different, previously used, cut-
offs for the FI. First of all, an FI of less than 0.2 was
considered as non-frail or ‘robust,’ a score between 0.2 and
0.35 as ‘pre-frail,’ and a score above 0.35 as ‘frail’ (Kul-
minski et al. 2008; Rockwood et al. 2007). Second, an FI-
score of B0.08 was considered non-frail, a score between
0.08 and 0.25 as pre-frail and a score equal to or higher
than 0.25 as frail, in accord with prior studies (Rockwood
et al. 2007; Rockwood et al. 2004; Song et al. 2010). Third,
we classified participants as non-frail if FI B0.10, frail if FI
C0.21, and pre-frail if the score was between 0.10 and
0.21, identified using stratum specific likelihood ratios
(Hoover et al. 2013).
Statistical analysis
First, baseline characteristics (gender, age, level of ID,
presence of Down syndrome), the mean FI-score and the
percentage of non-frail, pre-frail, and frail participants
were provided as the percentage for categorical variables
and the mean (with SD) for continuous variables. The
prevalence of each item of the phenotype was provided.
Second, the feasibility of the instruments was analyzed by
calculating the percentage of participants able to complete
the frailty assessments. A non-response analysis was per-
formed to compare the participants with and without
completed data for frailty, using a Pearson Chi-square for
categorical data and ANOVA for continuous data. Third,
the Cohen’s Kappa statistic was used to estimate agreement
between the instruments. For this analysis, the categorized
FI was compared with the frailty phenotype (e.g., non-frail,
pre-frail, frail). Agreement was considered as poor for
Kappa values lower than 0.21, slight for 0.21–0.40, mod-
erate for 0.41–0.60, good for 0.61–0.80, and excellent for
values 0.81–1 (Cohen 1960). Fourth, the ability to predict
5-year all-cause mortality was calculated for both instru-
ments and compared to each other. The hazard ratio’s (HR)
for mortality were calculated for the frailty phenotype and
for the categorized FI in separate Cox regression models.
Dummy variables were composed for the pre-frail and frail
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groups to compare their mortality risk with the non-frail
group. Additionally, the p for trend was provided. A
comparative analysis was performed by including the two
frailty instruments in one Cox regression model. This
analysis was repeated with an FI that excluded the criteria
that were also used for the frailty phenotype. In other
words, the deficits’ walking speed, grip strength, fatigue,
and weight loss were excluded from the FI. All models
were adjusted for age (years), level of ID (with dummy
variables for moderate and severe/profound), gender and
the presence of Down syndrome. A receiver operating
characteristics (ROC) curve was constructed and the area
under the ROC curve (AUC) was calculated to measure the
discriminative ability of the instruments in relation to
survival. These calculations were based on the Nearest
Neighbor Estimator, which uses time-dependent ROC and
AUC, to account for censoring (Heagerty et al. 2000). In
order to find the frailty variables that explained most
variance in survival time, we calculated the HR for each FI
item and for each frailty phenotype item. Additionally, we
added all available frailty measures (frailty phenotype and
FI) into a forward Cox Regression model. Full case anal-
ysis resulted in a small and very selective group. Therefore,
for this analysis, we used a multiple imputation procedure
using fully conditional specification (Markov chain Monte
Carlo method) with a maximum of 100 iterations. In total,
we created 10 imputed datasets using all the frailty mea-
sures as predictors in addition to the baseline characteris-
tics—Down syndrome, age, gender, and level of ID.
Because we used a stepwise entry of the variables, leading
to different predictor sets for the various imputation sets,
pooling of the results was impossible. We therefore provide
the results of the 10th imputation set. Fifth, the influence of
motor disability was assessed by including motor disability
into a Cox regression model.
For all survival analyses, the data on participants who
were lost to follow-up were censored and the proportional
Hazards assumption was tested with the scaled Schoenfeld
residuals. Statistical analyses were performed using SPSS
version 20.0 and R version 3.0.0. A two-sided p value of
\0.05 was considered significant.
Results
Sample characteristics
The mean age of the study sample (n = 1050) was 61.6
(SD = 8.0). Nearly half were female (n = 511, 49 %),
nearly half had a moderate level of ID (n = 506, 48 %),
and 14 % (n = 149) was diagnosed with Down syndrome.
According to the frailty phenotype, 230 (27 %) were
classified as non-frail, 508 (60 %) as pre-frail, and 110
(13 %) as frail. The mean FI-score was 0.27 (SD = 0.13).
Using the first defined cut-off (non-frail\ 0.2, frail[0.35),
325 (33.1 %) participants were classified as non-frail, 392
as pre-frail (37.3 %), and 265 as frail (25.2 %) according to
the FI. According to the second used cut-off (non-frail
B0.08, frail C0.25), 33 (3.4 %) were non-frail, 445 (45 %)
pre-frail, and 504 (51 %) frail. The third applied cut-off
(non-frail B0.10, frail C0.21) classified 65 (6.6 %) par-
ticipants as non-frail, 285 (29 %) as pre-frail, and 632
(64 %) as frail.
Feasibility
Less than a third of the participants (n = 307, 29 %) could
complete the full frailty phenotype assessment as intended.
40 % (n = 419) had four completed assessments, 12 %
(n = 122) had three completed assessments, and 19 %
(n = 202) had less than three completed assessments. By
including all participants with at least three known frailty
phenotype criteria, the frailty phenotype could be applied
to 848 (81 %) participants. Table 1 provides an overview
of the feasibility of the single frailty phenotype variables.
The 202 excluded participants were on average more
intellectually disabled (X2 = 32.8, p\ 0.001), and had on
average a higher FI-score (M = 0.31, SD = 0.12) than
those included ([M = 0.27, SD = 0.13], t(982) = 3.28,
p = 0.001). For other baseline characteristics, no signifi-
cant differences between the included and excluded par-
ticipants were found. For 167 participants (17.2 %), all 51
included deficits were known. In 68 (6.4 %) participants,
there was too much missing data to calculate an FI. There
were no significant associations between the number of
missing data and the FI-score or between the participants
with a known FI-score (n = 982, 94 %) and those without,
with respect to gender, age, level of ID, and Down
syndrome.
Agreement
For 838 participants, the frailty phenotype and the FI were
known. The Cohen’s Kappa agreement between the three
categorized FIs and the frailty phenotype ranged between
0.10 and 0.30, corresponding with poor till fair agreement
(Table 2). From the three applied FI cut-off values, only
the first (non-frail\0.2; frail[0.35) showed a fair agree-
ment with the frailty phenotype (Kappa agreement 0.3).
The two other applied FI cut-off points showed poor
agreement with the frailty phenotype (Kappa agreement
0.10 and 0.11). Each frailty phenotype variable was inde-
pendently of age, level of ID, gender, and Down syndrome
significantly associated with the FI (Table 1).
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Survival
Of the total HA-ID cohort (n = 1050), 207 participants
died during the follow-up. Table 3 shows the HR’s for pre-
frail and frail individuals, using the non-frail state as a
reference group, and the p for trend across all categories.
However defined, frailty was significantly related to mor-
tality. Those classified as pre-frail or frail using the frailty
phenotype were, respectively, 2.04 and 4.20 times more
likely to die during the follow-up period than those clas-
sified as non-frail. Those classified as pre-frail or frail with
the FI (using the\0.2 to define robust, and[0.35 to define
frail participants) were, respectively, 2.27 and 10.3 times
more likely to die than the non-frail group. If both instru-
ments were included in one Cox regression model, the
frailty phenotype no longer predicted mortality, whereas
the FI did. If all frailty phenotype items were excluded
from the FI, virtually the same results were obtained.
Although the HR for the frailty phenotype groups slightly
increased, they remained not significant (data not shown).
For the two FI scores that used the lowest cut-off of 0.08 or
0.10, two participants died in the reference group. There
was no association with mortality in the pre-frail and frail
participants compared to the reference group. The p for
trend was highly significant. Repeating the analysis with all
participants with a known FI (n = 982) revealed somewhat
stronger associations between the FI and mortality
(Table 6). The ROC curve showed that the first categorized
FI (robust\0.25, frail[0.35) had a higher discriminative
ability in relation to all-cause mortality (AUC = 0.78) than
the frailty phenotype (AUC = 0.64). The second (robust
B0.08, frail C0.25) and third cut values (robust B0.10, frail
C0.21) had an AUC of 0.69 and 0.66, respectively.
Almost all single frailty items were associated with
survival (Tables 1, 4). Mobility-related items of the
frailty phenotype (e.g., walking speed and physical
activity) were more strongly associated with both mor-
tality and the FI than the other items (e.g., grip strength,
weight loss, and exhaustion). The forward regression
analysis showed that a broad range of variables, includ-
ing walking stairs, present at the day care center, panic
attacks, asthma/COPD and hemoglobin, and fast fatigue,
were selected as independent predictors for survival
(Table 7).
Table 1 The variables of the frailty phenotype, feasibility, and association with survival and the frailty index
Association with Feasible (%) Classified as frail for this item n (%) Mortality
HR (95 % CI)a
Frailty index
B (SE)a
Grip strength 977 (93) 46 (4.4) 2.06 (1.13–3.74) 0.07 (0.06–0.09)
Weight loss 725 (69) 384 (53) 1.93 (1.13–3.31) 0.08 (0.05–0.11)
Exhaustion 975 (92) 171 (18) 1.95 (1.36–2.81) 0.11 (0.09–0.13)
Slow walking speed 818 (78) 271 (33) 3.64 (2.31–5.75) 0.15 (0.14–0.17)
Physical inactivity 422 (10) 255 (60) 5.43 (2.07–14.3) 0.14 (0.11–0.16)
a HR and B are adjusted for age, gender, level of ID, and the presence of Down syndrome. The regression coefficient B represents differences in
absolute frailty index score (and corresponding 95 % confidence interval)
Table 2 Agreement among the
frailty index (using different
cut-off values) and the frailty
phenotype based on three frailty
categories
n = 838a Frailty phenotype
Non-frail Pre-frail Frail Total Agreement
Frailty index Non-frail\0.2 151 146 2 299 0.30
Pre-frail 0.2–0.35 68 232 27 327
Frail[0.35 5 126 81 212
Total 224 504 110 838
Frailty index Non-frail B0.08 23 5 0 28 0.10
Pre-frail 0.08–0.25 162 235 8 405
Frail C0.25 39 264 102 405
Total 224 504 110 838
Frailty index Non-frail B0.10 45 12 0 57 0.11
Pre-frail 0.10–0.21 110 151 2 263
Frail C0.21 69 341 108 518
Total 224 504 110 838
a From the total HA-ID population (n = 1050), 838 had a known frailty phenotype and a frailty index
score
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Motor disability and frailty
Information on mobility was known for 989 participants. At
baseline, 731 (74 %) participants walked independently, 151
(15 %)walkedwith support, and107 (11 %)werewheelchair
dependent. Those who walked with support were 2.03 (95 %
CI = 1.40–2.97) times, and those who were wheelchair
dependent were 4.10 (95 % CI = 2.83–5.96) times, more
likely to have deceased during the follow-up compared to
those whowalked independently. The last column in Table 3
shows the relation of the two frailty approacheswith survival,
independent of motor disability at baseline. Although both
approaches remain significantly related with mortality, the
frailty phenotype loses much of its predictive value.
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each frailty instrument. All models were adjusted for age, gender, level of ID, and Down syndrome. Participants were excluded if they had
missing data on one of the frailty instruments, motor disabilities, or other covariates (n = 232). The model motor disability was adjusted for the
level of motor impairment, ‘no walking impairment’ was used as a reference category; the model for motor disability included only the frailty
phenotype or the frailty index
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Discussion
In this prospective population-based study, we compared
two concepts of frailty in older people with ID: the frailty
phenotype and the FI. The FI was more often feasible in the
ID population than the frailty phenotype. Both instruments
were valid in terms of predicted value for survival; partici-
pants classified as frail by either instrument had increased
5-year mortality risks. Even so, people designated as frail by
the FI were more likely to decease than those designated as
frail by the frailty phenotype. However, the CIs for the FI
were wider than the CIs observed for the frailty phenotype,
indicating a larger uncertainty in the estimation. Motor dis-
abilities are an important risk factor for mortality. After
adjusting the survival models for motor disability, both, but
mainly the frailty phenotype, lost predictive value. Previ-
ously, we suggested that the FI might be a more suit-
able concept for this population because of lifelong
disabilities (Evenhuis et al. 2013). The current results con-
firm this suggestion.
The FI could be calculated for 94 % of the participants,
whereas the frailty phenotype was feasible in 81 %. For less
than a third of the participants (29 %), all frailty phenotype
criteria could be measured. This is in agreement with results
from studies among assisted-living participants, where
nearly 40 % could not complete the assessment (de la Rica-
Escuin et al. 2014; Hogan et al. 2012). This dropout was
mainly caused by more severe cognitive impairment and
chronic comorbidity. This result is in line with results
observed in the general population: persons in whom the
phenotype cannot be measured completely are significantly
more disabled, have more chronic diseases, are more likely
to die, and have a higher FI-score (Collerton et al. 2012;
Ravindrarajah et al. 2013). On the other hand, dropout for the
FI appeared to be random. The agreement between the two
instruments was lower compared to other studies (Theou and
Rockwood 2015) and the associations between each single
frailty phenotype measure and the FI were rather weak, in
contrast to others (Hoogendijk et al. 2015).
In accordance with findings in the general population, we
found that the predictive value and thereby the criterion
validity for the FI is stronger than that of the frailty phenotype
(Blodgett et al. 2015;Hogan et al. 2012;Kulminski et al. 2008;
Rockwood et al. 2007; Theou andRockwood2015;Woo et al.
2012). There are several explanations for our results.
First, the FI has a much broader approach than the frailty
phenotype. It includes all factors that are considered
important for frailty (e.g., nutritional status, physical
activity, energy, cognition) (de Vries et al. 2011; Gobbens
et al. 2010). In contrast, the frailty phenotype focuses on
physical frailty only. It appears that, among the highly
heterogeneous ID population, physical parameters do only
explain part of the variance. Indeed, our forward regression
analysis implies that, although physical variables are
extremely important, disabilities, diseases, and cognition
independently add to the explained variance of the model.
Second, and in line with the first suggestion, the frailty
phenotype seems to be too determined by mobility limi-
tations. Indeed, in our study the frailty phenotype had only
limited additional predictive value to motor disabilities
alone. This limits the predictive value of the frailty phe-
notype, because motor disabilities appear to be less strong
predictors for mortality in our ID sample than observed in
the general population (Feeny et al. 2012; Majer et al.
2011). Lifelong or early motor impairment, which is
common in this population, is likely to be less predictive
than motor impairment acquired in later life.
Third, the phenotype approach has the advantage that it
focuses on five core clinical features, that are, in theory,
easy to measure. Nevertheless, these pre-defined elements
are not measurable in all individuals with an ID. This
appears less of a problem with the FI approach, which does
not require the use of a pre-defined set of variables or even
the same number of variables (Rockwood et al. 2006). We
were therefore able to design an FI for the ID population,
whereas the elements of the frailty phenotype are designed
for the general population.
Fourth, we were unable to apply the exact parameters as
those proposed in the Cardiovascular Health Study to
measure the frailty phenotype. This could have led to an
unknown shift in its predictive validity (Theou et al. 2015).
In addition, the analyses were applied to participants with
at least three elements of the frailty phenotype measured. It
is likely that this caused an underestimation of the true
frailty prevalence. Measurements that are more feasible for
the ID population might have increased the predictive
validity of the frailty phenotype. For example, it is known
that physical activity is hard to measure with pedometers in
people with ID (Hilgenkamp et al. 2012). Using an
instrument such as the StepWatch or GPS could have led to
more valid results for the element ‘physical activity’ (van
Schijndel-Speet et al. submitted).
Nevertheless, overall the frailty phenotype showed a
strong relation with mortality, indicating that physical fit-
ness and mobility are important to lengthen the lifespan.
Specifically, the mobility-related frailty phenotype items
(e.g., walking speed and physical inactivity) were most
strongly associated with both mortality and the FI. The
group with low physical activity and low walking speed
also includes those bound to a wheelchair. These results
indicate that even though mobility impairment is less
predictive for mortality than observed in the general pop-
ulation, it is a very important risk factor for mortality and
overall health (e.g., the FI). It has been shown in the HA-ID
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study that elements from the frailty phenotype (e.g., grip
strength, walking speed) predict disability in mobility and
activities of daily living (Oppewal et al. 2014). In the
general population, physical activity and fitness can reduce
or prevent frailty (Liu and Fielding 2011; Theou et al.
2011). Whether increased physical fitness and activity will
also reduce or delay frailty in people with ID needs to be
investigated.
The main strength of our study is its large-scale and
prospective population-based design, in which we used
standardized and internationally accepted methods to
measure frailty. Nevertheless, several limitations need to
be taken into account. First, although the population was
near-representative, older people with ID using specialized
support, living independently or with relatives were
slightly underrepresented in the HA-ID study. Because of
the high correlation between frailty and more severe ID,
this underrepresentation might have caused slightly higher
prevalence of frailty (Hilgenkamp et al. 2011). Second, we
did not take into account time and costs as feasibility
aspects. It is very likely that regarding costs, the frailty
phenotype is more feasible for clinical practice. Never-
theless, with this study we mainly wanted to better
understand frailty and its consequences in this population.
For the clinical implementation of any frailty instrument,
time and cost should be taken into account. Third, we
studied the relation between frailty and survival because
mortality is an easily verifiable, dichotomous, and non-
arbitrary outcome. Nevertheless, other health outcomes
including care need, hospitalization, and disabilities are
needed to obtain full insight into the negative consequences
of frailty in people with ID. Fourth, the frailty phenotype
and the FI are the two most commonly applied concepts.
Nevertheless, there are other concepts and frailty instru-
ments that were not included in this study. These measures
were chosen because they allow objective measurements,
which are needed in a population where only about 25 % is
capable of reliable, self-report. In addition, the baseline
data of the HA-ID study were already collected before
frailty became of interest. Therefore, we were limited to
frailty instruments that could be constructed using the
available data. In addition, there is value using the two
most commonly used measurements in connecting to a
large body of published work in order to compare popu-
lation characteristics. Last, it has been advised to use the FI
as a continuous scale, and not apply cut points. Even so, for
the sake of comparing the FI with the three frailty strata,
proposed by Fried et al., we created three frailty groups
applying three different cut points. Nevertheless, the cut
points that classified individuals as robust if the FI was
below 0.10 or 0.08 resulted in small groups of robust
participants and, in line with expectations regarding these
robust individuals, limited number of deaths were
observed. Using the robust group as a reference group was
therefore complicated and resulted in underpowered HRs.
We therefore placed most emphasis on the first applied cut
value (robust if FI was below 0.20). In order to better
understand the agreement and validation of different cut
points, a longer follow-up and/or more participants are
required.
The two frailty concepts used in our study have a dif-
ferent purpose and different underlying justification. Nev-
ertheless, by comparing the two different concepts, we
tried to improve the understanding of frailty in people with
ID. The cycle of frailty, which serves as the biological
basis of the frailty phenotype, might not be the only rele-
vant aspect in the ID population. Mainly because in this
cycle of age-related decline, it is supposed that its indi-
vidual components are associated with each other and with
further physiological losses, disability, dependency, and
eventually death. In contrast, in our population motor dis-
abilities can be lifelong and congenital and childhood
disabilities are more likely to contribute to frailty than the
other way around. For example, it was observed that,
according to the frailty phenotype, people with motor
disabilities were very likely to also be frail or pre-frail;
only 8 % of the participants using a walking aid or
wheelchair were classified as robust (Evenhuis et al.,
2012). The FI, within clearly defined borders, simply
counts how many things are wrong with an individual.
Even though the FI also includes lifelong disabilities, it
seems that these lifelong problems less influence its
validity. Nevertheless, also in people with ID, disabilities
increase as a consequence of aging and frailty (Schoufour
et al. 2014, 2015). Therefore, identifying frail individuals
can assist clinicians in identifying people at risk for adverse
health outcomes, who may thereafter benefit from
interventions.
Although efforts have been made, there is not yet a
validated frailty screening instrument for the ID population
(Brehmer-Rinderer et al. 2013). Screening and monitoring
the health status of people with ID can potentially have
great beneficial effects because recovering from a frail state
is complicated, putting more emphasis on early detection
and prevention (Rockwood et al. 2011). As the FI provides
the highest feasibility and the highest predictive validity,
we advise to screen for frailty using an FI like approach.
Nevertheless, several steps need to be taken into account
before the FI can be applicable to clinical practice. The
original FI is composed of 51 items, of which some are not
applicable to clinical practice (for example, the block test
to measure manual dexterity and the DDS questionnaire to
diagnose dysphagia). It should be studied whether the FI
remains valid after the removal of less clinically applicable
measures. Also, the stability of the FI should be tested by
determining the test–retest reliability. Additionally, it is yet
70 Eur J Ageing (2017) 14:63–79
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unclear if the FI is sensitive to changes over time. In the
long run, routinely collected data might be used to calcu-
late an FI and monitor frailty status over time.
With this study, we aimed to better understand frailty in
people with ID by applying two different frailty instru-
ments. Our results imply that the used FI is a stronger pre-
dictor for mortality than our adaptation of the phenotype in
the population of older people with ID. Possible explana-
tions of our findings are that we did not use the exact frailty
phenotype variables or that the FI includes multiple health
domains. The differences between the two frailty approa-
ches may also be caused by the FI being less determined by
lifelong disability and mobility, compared to the frailty
phenotype. We suggest that future studies on frailty in
people with ID take into account that the feasibility of frailty
instruments can be hampered, and adapted instruments are
required. Furthermore, lifelong disabilities, such as mobility
impairment, could influence the prevalence of frailty and
the validity of frailty instruments. Although we acknowl-
edge mobility impairment as a very important aspect of
frailty, we suggest using multiple frailty domains, in order
to capture the risk for mortality the best. Future research
needs to focus on the clinical feasibility of the FI. Particu-
larly, it should be studied whether routinely collected data
can be used to construct an FI for people with ID.
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Appendix
See Tables 4, 5, 6, and 7.
Table 4 Overview of deficits included in the frailty index (n = 982)
# Deficit Additional information Cut-off values and FI scores Percentage per
category
HR (95 % CI)a p (for trend)
1 Bladder control ADL, Completed by
professional caregivers
of the participants
Incontinent = 1 23.1 3.86 (2.70–5.52) \0.001
Sometimes continent = 0.5 24.1 1.39 (0.92–2.08)
Continent = 0 52.7 –
2 Dressing ADL, Completed by
professional caregivers
of the participants
Needs help = 1 19.0 5.48 (3.70-8.13) \0.001
Partly with help = 0.5 25.8 2.04 (1.38–3.02)
No help = 0 55.2 –
3 Walking stairs ADL, Completed by
professional caregivers
of the participants
Needs help = 1 27.6 4.53 (3.12–6.58) \0.001
Partly with help = 0.5 20.7 1.75 (1.12–2.73)
No help = 0 51.7 –
4 Bathing ADL, Completed by
professional caregivers
of the participants
With help = 1 64.3 2.50 (1.65–3.80) \0.001
No help = 0 35.7 –
5 Transfer bed to chair ADL, Completed by
professional caregivers
of the participants
Unable, no sitting balance = 1 9.4 4.79 (3.22–7.12) \0.001
Major help = 0.66 3.0 5.17 (3.00–8.90)
Minor help = 0.33 13.2 2.71 (1.82–4.01)
No help = 0 74.4 –
6 Groceries IADL, completed by
professional caregivers
of the participants
Not independently = 1 51.2 3.08 (1.93–4.93) \0.001
With help = 0.5 20.9 1.12 (0.63–1.98)
Can do groceries = 0 27.9 –
7 Housekeeping IADL, completed by
professional caregivers
of the participants
Not independently = 1 74.6 3.75 (1.51–9.29) 0.001
With help = 0.5 15.2 1.58 (0.56–4.51)
Can do housekeeping = 0 10.2 –
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Table 4 continued
# Deficit Additional information Cut-off values and FI scores Percentage per
category
HR (95 % CI)a p (for trend)
8 Falling Number of falls in the last
three months.
Information gathered
via the professional care
giver
[11 falls = 1 1.3 2.61 (1.07–6.41) 0.016
6–10 falls = 0.75 1.0 1.60 (0.39–6.56)
3–5 falls = 0.5 3.8 2.27 (1.27–4.06)
1–2 falls = 0.25 17.4 1.31 (0.91–1.87)
0 falls = 0 76.4 –






\3 visits a week = 1 15.7 1.82 (1.27–2.59) 0.001
C3 visits a week = 0 84.3 –
10 Fatigued ADESS (Dutch
translation of the
Anxiety, Depression
And Mood Scale) over
the past six months.
Completed by
professional caregivers
Very often = 1 6.0 3.36 (3.36–2.06) \0.001
Often = 0.66 17.3 1.85 (1.85–1.24)
Sometimes = 0.33 30.9 1.67 (1.67–1.17)
Never = 0 45.8 –
11 Listless ADESS (Dutch
translation of the
Anxiety, Depression
And Mood Scale) over
the past six months.
Completed by
professional caregivers
Very often = 1 3.2 3.54 (2.05–6.13) \0.001
Often = 0.66 8.6 1.87 (1.19–2.95)
Sometimes = 0.33 23.7 1.46 (1.04–2.04)
Never = 0 64.5 –
12 Panic attacks ADESS (Dutch
translation of the
Anxiety, Depression
And Mood Scale) over
the past six months.
Completed by
professional caregivers
Very often = 1 3.4 3.47 (2.00–6.06) \0.001
Often = 0.66 6.8 1.44 (0.85–2.43)
Sometimes = 0.33 13.7 1.71 (1.17–2.50)
Never = 0 76.1 –
13 Decreased food







over the past three
months. Completed by
professional caregivers
Severe decrease in food
intake = 1
4.3 2.61 (1.61–4.22) \0.001
Moderate decrease in food
intake = 0.5
9.5 1.94 (1.31–2.87)
No decrease in food intake = 0 86.2 –
14 Weight loss Mini Nutritional
Assessment (MNA)
over the past three
months. Completed by
professional caregivers
Weight loss greater than
3 kg = 1
Does not know = 0.5
4.7 – 0.023
Weight loss 1–3 kg = 0.5 24.2 2.05 (1.20–3.52)
No weight loss = 0 71.0 1.24 (0.90–1.73)





over the past three
months. Completed by
professional caregivers
Less than 3 cups = 1 0.5 10.9 (3.94–30.0) \0.001
1 to 5 cups = 0.5 14.8 1.13 (0.77–1.65)







CC\ 31 = 1 21.3 1.92 (1.39–2.67) \0.001
CC C 31 = 0 78.7 –
17 Only eats selected
types of food (e.g.,
pudding, rice)





[ 10 times = 1 4.5 1.73 (1.04–2.90) \0.001
Between 1–10 times = 0.5 3.9 2.84 (1.68–4.79)
Not at all/not a problem = 0 91.6 –
18 Only eats small
amounts of the
presented food





[ 10 times = 1 4.2 1.95 (1.12–3.41) 0.025
Between 1–10 times = 0.5 12.2 1.39 (0.95–2.04)
Not at all/not a problem = 0 83.6 –
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Table 4 continued
# Deficit Additional information Cut-off values and FI scores Percentage per
category
HR (95 % CI)a p (for trend)
19 Only eats foods of
certain textures





[ 10 times = 1 5.4 2.61 (1.65–4.14) \0.001
Between 1–10 times = 0.5 2.5 2.36 (1.26–4.39)
Not at all/not a problem = 0 92.1 –
20 Mobility Provided by professional
caregivers
Wheelchair = 1 10.9 4.10 (2.83–5.96) \0.001
Walks with support = 0.5 15.3 2.04 (1.40–2.97)
Walks independently = 0 73.8 –
21 CVA Medical file, last
24 months
Yes = 1 94.0 1.57 (0.95–2.59) 0.080








Yes = 1 9.2 2.26 (1.51–3.38) \0.001
No = 0 90.8 –
23 Cancer Medical file, entire life Yes = 1 4.9 1.27 (0.70–2.31) 0.43
No = 0 95.1 –
24 Asthma/COPD Medical file, last
24 months, mediation
Yes = 1 13.2 2.27 (1.60–3.24) \0.001
No = 0 86.8 –
25 GERD Medical file, last
24 months
Yes = 1 20.0 1.52 (1.07–2.15) 0.02
No = 0 80.0 –
26 Obstipation Medical file, last
24 months, medication
Yes = 1 39.7 2.02 (1.48–2.76) \0.001
No = 0 60.3 –






DM according to medical file or
taking drugs for DM and/or
serum glucose C 7 mmol/
l = 1
12.4 1.17 (0.76–1.80) 0.75
No DM according to medial file,
no DM drugs and blood
glucose 6.1–6.9 = 0.5
2.7 0.90 (0.33–2.43)
No DM according to medial file,
no DM drugs and blood
glucose\ 6.1 = 0
84.8 –
28 Scoliosis Medical file Yes = 1 10.6 1.27 (0.81–1.99) 0.30




Medical file At least one severe V/H
impairment = 1






No V/H impairment = 0 45.5 –
30 Medication use
(polypharmacy)
Medical file C 7 drugs = 1 19.8 3.12 (2.13–4.67) \0.001
4–6 drugs = 0.5 31.2 1.75 (1.21–2.52)
0–3 drugs = 0 48.9 –
31 Over or under weight Medical examination BMI\ 18.5 OR[ 30 = 1 27.7 1.44 (0.93–2.23) 0.15
BMI 18.5–20 OR 25–30 = 0.5 41.0 1.01 (0.68–1.51)
BMI 20–25 = 0 31.3 –
32 High blood pressure Medical file Yes = 1 21.5 0.94 (0.64–1.39) 0.76
No = 0 78.5 –
33 Peripheral
atherosclerosis
Medical examination Ankle Arm index 0.005
[0.9 = 1 9.9 1.90 (1.15–3.15)
0.8–0.9 = 0.5 12.2 1.86 (1.17–2.97)
\0.8 = 0 78.0 –
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Table 4 continued
# Deficit Additional information Cut-off values and FI scores Percentage per
category
HR (95 % CI)a p (for trend)
34 Osteoporosis (t-score) Medical examination \2.5 = 1 32.7 1.14 (0.72–1.81) 0.109
-1 till -2.5 = 0.5 38.8 0.72 (0.45–1.14)





asked to move as many
colored blocks as
possible in one minute.
The blocks were
2.5 cm3 and needed to
be moved from one side
of a wooden box to the
other side
Lowest quartile = 1 26.8 2.75 (1.51–5.00) \0.001
Second quartile = 0.66 21.6 1.04 (0.55–1.97)
Third quartile = 0.33 26.1 0.83 (0.45–1.53)
Highest quartile = 0 25.7 –
36 Walking speed Fitness assessment
Comfortable walking
speed was measured by
the average of three
records of the time
needed to complete 5
meters after 3 meters
for acceleration
Slow walking speed was
Stratified for height and gender
64.7 3.27 (2.27–4.71) \0.001
Male
height B 173 cm C 7 s = 1
Male
height[ 173 cm C 6 s = 1
Females
height B 159 cm C 7 s = 1
Females[ 159 cm C 6 s = 1
Faster = 0 35.3 –
Participant who were not able to
succeed the walking speed
assessment due to physical
limitations were scored positive
(score 1) as well
Slow walking speed was
Stratified for height and gender
37 Grip strength Fitness assessment









Below cut-off values = 1
Male
BMI B24: C29 kg = 0
BMI 24.1–26: C30 kg = 0
BMI 26.1–28: C30 kg = 0
BMI[28: C32 kg = 0
Female
BMI B23: C17 kg = 0
BMI 23.1–26: C17.3 kg = 0
BMI 26.1–29: C18 kg = 0
BMI[29: C21 kg = 0
Participant who were not able to
succeed the grip strength
assessment due to physical
limitations were scored positive
(score 1) as well
38 Hypercholesterolemia Medical registry Yes = 1 10.0 0.58 (0.30–1.11) 0.58
No = 0 90.0 –
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Table 4 continued
# Deficit Additional information Cut-off values and FI scores Percentage per
category
HR (95 % CI)a p (for trend)
39 HDL Blood examination HDL was stratified for gender 24.6 1.17 (0.69–1.98) 0.49
Male 59.0 0.92 (0.56–1.50)
0–0.9 mmol/l = 1 16.4 –
0.9–1.55 mmol/L = 0.5
[1.55 mmol/L = 0
Female
0–1.1 mmol/l = 1
1.1–1.55 mmol/L = 0.5
[1.55 mmol/L = 0
40 Hemoglobin Blood examination Stratified for gender 23.8 2.67 (1.87–3.08) \0.001
Male 76.2 –
8.6–10.5 mmol/L = 0
\8.6 OR[ 10.5 mmol/L = 1
Female
7.5–9.5 mmol/L = 0
\7.5 OR[ 9.5 mmol/L = 1
41 Dysphagia Diagnosis via DDS
questionnaire
Severe dysphagia = 1 52.0 2.10 (1.29–3.42) 0.006
Moderate dysphagia = 0.5 26.1 1.52 (0.88–2.63)
No Dysphagia = 0 21.8 –




[2 = 1 0.6 8.57 (2.59–28.3) \0.001
1–2 = 0.5 11.0 1.74 (1.16–2.62)
No = 0 88.4 –






Often = 1 4.6 4.54 (2.48–7.94) \0.001
Several times = 0.66 12.9 1.97 (1.23–3.15)
Sometimes = 0.33 36.9 1.87 (1.31–2.68)
Never/very rare = 0 45.6 –





Never/very rare = 1 4.7 3.06 (1.68–5.57) 0.001
Sometimes = 0.66 19.2 1.99 (1.30–3.06)
Several times = 0.33 39.1 1.40 (0.94–2.08)
Often = 0 36.9 –
45 Sleeps more than
regularly (trouble






Often = 1 4.5 4.55 (2.68–7.72) \0.001
Several times = 0.66 9.8 2.85 (1.84–4.42)
Sometimes = 0.33 22.8 1.96 (1.35–2.85)
Never/very rare = 0 62.9 –
46 Fast fatigued/listless SDZ, completed by
professional caregivers
Last three months
Often = 1 6.4 4.57 (2.82–7.39) \0.001
Several times = 0.66 13.5 2.03 (1.28–3.21)
Sometimes = 0.33 35.3 1.62 (1.11–2.37)
Never/very rare = 0 44.8 –





Never/very rare = 0
Sometimes = 0.33
















Normally No = 1 57.4 1.55 (1.04–2.27) 0.09
Sometimes = 0.5 5.3 1.18 (0.57–2.45)
Normally Yes = 0 37.2 –






Normally No = 1 12.6 3.43 (2.36–5.00) \0.001
Sometimes = 0.5 7.6 2.44 (1.56–3.97)
Normally Yes = 0 79.8 –
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Table 4 continued
# Deficit Additional information Cut-off values and FI scores Percentage per
category
HR (95 % CI)a p (for trend)




Normally No = 1 36.2 2.50 (1.59–3.91) \0.001
Sometimes = 0.5 36.5 1.59 (1.03–2.46)
Normally Yes = 0 27.3 –
51 Knowing that today is






Normally No = 1 23.5 3.56 (2.46–5.16) \0.001
Sometimes = 0.5 9.7 2.06 (1.28–3.30)
Normally Yes = 0 66.8 –
a HR Hazard ratio, calculated for each provided category using the ‘healthiest’ option as a reference group; HR are adjusted for age, gender, level
of ID, and the presence of Down syndrome
Table 5 Frailty phenotype variables as originally intended by Fried et al. (2001, 2012) and the adapted frailty phenotype by Evenhuis et al.
(2012)
Original measurement Applied to the HA-ID study
Weakness Grip strength: lowest 20 % (by
gender, body mass index)
As originally suggested using the Jamar Hand Dynamometer [#5030J1, Sammons
Preston Rolyan, Dolgeville, NY]
Shrinking:
Weight loss
[10 lbs (4.54 kg) lost
unintentionally in prior year
An item of the Mini Nutritional Assessment,
weight loss during the past 3 months was assessed on a
4-point rating scale. Losses[3 kg were scored
Exhaustion Exhaustion by self-report Exhaustion was estimated using the
item ‘‘Lacks energy’’ of the Anxiety, Depression and
Mood Scale, using a 4-point rating scale. No exhaustion was classified as no problems or
mild problems and exhaustion was classified as moderate problem and severe problem.
Because self-report is difficult for a large part of the intellectual disabled population,
proxy-based answers were used
Slowness Walking time/15 ft: slowest 20 %
(by gender, height)
As originally suggested. In addition, all participants in a wheelchair and all participants
who could not engage in the walking speed assessment because of physical limitations
were classified as ‘slow’
Low activity kcal/week: lowest 20 %
males:\383 kcal/week
females:\270 kcal/week
All participants walking fewer than 5000 steps/day (sedentary lifestyle) were scored as
‘low activity,’ as were all participants in a wheelchair and all participants who could
not engage in the walking speed assessment because of physical limitations
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